CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.
Elizabeth GrayAlexander Guy ThompsonJoanne WuuJoe PeltKevin TalbotMichael BenatarMatthew C KiernanPublished in: Annals of clinical and translational neurology (2020)
The CHIT1 neuroinflammatory response is a feature of the late presymptomatic to early symptomatic phases of ALS. This study does not suggest a long prodrome of upregulated glial activity in ALS pathogenesis, but strengthens the place of CHIT1 as part of a panel of biomarkers to objectively assess the impact of immune-modulatory therapeutic interventions in ALS.